← Patent-cliff monitor Endo Pharmaceuticals is a Massachusetts-based company.
7 upcoming patent cliffs Drug Ingredient Type Cliff
OPANA ER OXYMORPHONE HYDROCHLORIDE Small mol. Nov 2029 OPANA ER OXYMORPHONE HYDROCHLORIDE Small mol. Nov 2029 OPANA ER OXYMORPHONE HYDROCHLORIDE Small mol. Nov 2029 OPANA ER OXYMORPHONE HYDROCHLORIDE Small mol. Nov 2029 OPANA ER OXYMORPHONE HYDROCHLORIDE Small mol. Nov 2029 OPANA ER OXYMORPHONE HYDROCHLORIDE Small mol. Nov 2029 OPANA ER OXYMORPHONE HYDROCHLORIDE Small mol. Nov 2029 SYMMETREL AMANTADINE HYDROCHLORIDE Small mol. — MOBAN MOLINDONE HYDROCHLORIDE Small mol. — DELATESTRYL TESTOSTERONE ENANTHATE Small mol. — DELATESTRYL TESTOSTERONE ENANTHATE Small mol. — OPANA OXYMORPHONE HYDROCHLORIDE Small mol. — OPANA OXYMORPHONE HYDROCHLORIDE Small mol. — NUMORPHAN OXYMORPHONE HYDROCHLORIDE Small mol. — SYMMETREL AMANTADINE HYDROCHLORIDE Small mol. — OPANA OXYMORPHONE HYDROCHLORIDE Small mol. — OPANA OXYMORPHONE HYDROCHLORIDE Small mol. — SYMMETREL AMANTADINE HYDROCHLORIDE Small mol. — VALPIN 50 ANISOTROPINE METHYLBROMIDE Small mol. — Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.